Citation Impact
Citing Papers
A Stem Cell–Based Approach to Cartilage Repair
2012 Science
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
The landscape of human tissue and cell type specific expression and co-regulation of senescence genes
2022
Proteomic Analysis Reveals a Role for Bcl2-associated Athanogene 3 and Major Vault Protein in Resistance to Apoptosis in Senescent Cells by Regulating ERK1/2 Activation
2014
Sox9 Modulates Proliferation and Expression of Osteogenic Markers of Adipose-Derived Stem Cells (ASC)
2013 Standout
Strategies and New Developments in the Generation of Patient-Specific Pluripotent Stem Cells
2007 StandoutNobel
Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility
2010
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Cancer to bone: a fatal attraction
2011 Standout
Signal Transduction by the JNK Group of MAP Kinases
2000 Standout
Runx2: A master organizer of gene transcription in developing and maturing osteoblasts
2005
Smad transcription factors
2005 Standout
AP-1: a double-edged sword in tumorigenesis
2003 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Mesenchymal stem cells in joint disease and repair
2013
Bone morphogenetic protein receptors and signal transduction
2009 Standout
The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3
1998 Nature
Elite and stochastic models for induced pluripotent stem cell generation
2009 StandoutNatureNobel
Hallmarks of aging: An expanding universe
2023 Standout
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells transformed with c-myc and H-ras form high-grade glioma after stereotactic injection into the rat brain
1998
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
AP-1 as a regulator of cell life and death
2002 Standout
Fortuitous convergences: the beginnings of JUN
2002
Promoter 2 -1025 T/C Polymorphism in the RUNX2 Gene Is Associated with Femoral Neck BMD in Spanish Postmenopausal Women
2007
Osteoarthritis
2015 Standout
Skeletal remodeling in health and disease
2007 Standout
RIBEYE, a Component of Synaptic Ribbons
2000 StandoutNobel
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Cancer genes and the pathways they control
2004 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
KLF4, p21 and context-dependent opposing forces in cancer
2005
Identification of Putative Target Genes of the Transcription Factor RUNX2
2013 StandoutNobel
Cloning and characterization of mCtBP2, a co-repressor that associates with basic Kruppel-like factor and other mammalian transcriptional regulators
1998
Novel Roles for MLH3 Deficiency and TLE6-Like Amplification in DNA Mismatch Repair-Deficient Gastrointestinal Tumorigenesis and Progression
2008 StandoutNobel
p21 in cancer: intricate networks and multiple activities
2009 Standout
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase
2005 StandoutNobel
Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
1997
A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun
2003
Intrinsically disordered proteins in cellular signalling and regulation
2014 Standout
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
2012 Standout
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death
2000
The Runx genes: lineage-specific oncogenes and tumor suppressors
2004
Oncogene-induced senescence: the bright and dark side of the response
2010
c-Jun NH2-terminal Kinases Target the Ubiquitination of Their Associated Transcription Factors
1997
Regulatory T cells: roles of T cell receptor for their development and function
2010 StandoutNobel
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
The runx genes: gain or loss of function in cancer
2005
Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation
1998
The Hallmarks of Aging
2013 Standout
RUNX Genes in Development and Cancer: Regulation of Viral Gene Expression and the Discovery of RUNX Family Genes
2007
AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy
2011
Nrf2-ARE stress response mechanism: A control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases
2010
The stress-activated protein kinase pathways
1999
Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus
2005
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
2000 Standout
Cisplatin nephrotoxicity
2003 Standout
Genomic Promoter Occupancy of Runt-related Transcription Factor RUNX2 in Osteosarcoma Cells Identifies Genes Involved in Cell Adhesion and Motility
2011
Cellular senescence: from physiology to pathology
2014 Standout
The Stress Kinase Mitogen-Activated Protein Kinase Kinase (Mkk)7 Is a Negative Regulator of Antigen Receptor and Growth Factor Receptor–Induced Proliferation in Hematopoietic Cells
2001 StandoutNobel
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
v-Jun Overrides the Mitogen Dependence of S-Phase Entry by Deregulating Retinoblastoma Protein Phosphorylation and E2F-Pocket Protein Interactions as a Consequence of Enhanced Cyclin E-cdk2 Catalytic Activity
2000
The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling
2001
Analysis of Candidate Genes for Lineage-Specific Expression Changes in Humans and Primates
2014 StandoutNobel
Signal transduction by reactive oxygen species
2011 Standout
Repression of Bone Morphogenetic Protein and Activin-inducible Transcription by Evi-1
2005
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Association of Functionally Different RUNX2 P2 Promoter Alleles With BMD
2006
HDAC4, a Human Histone Deacetylase Related to Yeast HDA1, Is a Transcriptional Corepressor
1999
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
2005 Standout
Runx1 Directly Promotes Proliferation of Hair Follicle Stem Cells and Epithelial Tumor Formation in Mouse Skin
2010
Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors
2007 StandoutNobel
Current Understanding of Pathogenesis and Treatment of TMJ Osteoarthritis
2015 Standout
Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell Apoptosis
2008
Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation
1999
Controlling TGF-beta signaling.
2000 Standout
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Smad Transcriptional Corepressors in TGFβ Family Signaling
2001
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
Post-translational Regulation of Runx2 in Bone and Cartilage
2009
Works of Anna Kilbey being referenced
Runx Regulation of Sphingolipid Metabolism and Survival Signaling
2010
v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
1998
Evi-1 Transforming and Repressor Activities Are Mediated by CtBP Co-repressor Proteins
2001
Oncogene-induced senescence: An essential role for Runx
2008
Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts
1998
The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation
1997
Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival
2008
Conservation and expression of an alternative 3′ exon of Runx2 encoding a novel proline-rich C-terminal domain
2004
RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress
2009
The Runx genes as dominant oncogenes
2003
RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53
2004
Differential regulation of AP-1 and novel TRE-specific DNA-binding complexes during differentiation of oligodendrocyte-type-2-astrocyte (O-2A) progenitor cells
1995
Transcriptional activation by the v-Jun oncoprotein is independent of positive regulatory phosphorylation.
1994
Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
2002
Runx2 Disruption Promotes Immortalization and Confers Resistance to Oncogene-Induced Senescence in Primary Murine Fibroblasts
2007
The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
1996